![]() | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C19H11ClF3N3O3 |
| Molar mass | 421.8 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
CM-4620 is a drug which acts as a selective inhibitor of the calcium channel ORAI1. It has antiinflammatory effects and is being researched for the treatment of pancreatitis.[1]
References
- ↑ Waldron RT, Chen Y, Pham H, Go A, Su HY, Hu C, et al. (June 2019). "The Orai Ca2+ channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitis". The Journal of Physiology. 597 (12): 3085–3105. doi:10.1113/JP277856. PMC 6582954. PMID 31050811.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
